The invention is directed to devices and methods for brain stimulation including deep brain stimulation. In addition, the invention is directed to devices and method for brain stimulation using a lead having embedded segmented electrodes
Deep brain stimulation can be useful for treating a variety of conditions including, for example, Parkinson's disease, dystonia, essential tremor, chronic pain, Huntington's Disease, levodopa-induced dyskinesias and rigidity, bradykinesia, epilepsy and seizures, eating disorders, and mood disorders. Typically, a lead with a stimulating electrode at or near a tip of the lead provides the stimulation to target neurons in the brain. Magnetic resonance imaging (MRI) or computerized tomography (CT) scans can provide a starting point for determining where the stimulating electrode should be positioned to provide the desired stimulus to the target neurons.
Upon insertion, current is introduced along the length of the lead to stimulate target neurons in the brain. This stimulation is provided by electrodes, typically in the form of rings, disposed on the lead. The current projects from each electrode similarly and in all directions at any given length along the axis of the lead. Because of the shape of the electrodes, radial selectivity of the current is minimal. This results in the unwanted stimulation of neighboring neural tissue, undesired side effects and an increased duration of time for the proper therapeutic effect to be obtained.
One embodiment is a method of manufacturing a device for brain stimulation. The method includes forming a lead body having a distal end section and coupling at least one pre-electrode to the distal end section of the lead body. The pre-electrode defines a divider with a plurality of partitioning arms, and has a plurality of fixing lumens. A portion of the pre-electrode aligned with the portioning arms is removed to divide the pre-electrode into a plurality of segmented electrodes. Each of the plurality of segmented electrodes defines at least one of the plurality of fixing lumens at least partially disposed through the segmented electrode. A material is introduced through the at least one fixing lumen to couple the plurality of segmented electrodes to the lead body.
Another embodiment is a device for brain stimulation that includes an insulative tubing having a distal end section and at least one electrode frame disposed on the distal end section of the insulative tubing. The at least one electrode frame is formed of an insulative material. Each of the at least one electrode frame defines at least one electrode cavity. The device also includes a plurality of segmented electrodes with at least one of the plurality of segmented electrodes disposed within each of the at least one electrode cavity.
Yet another embodiment is a method of manufacturing a device for brain stimulation. The method includes forming an insulative carrier having a plurality of apertures for receiving a plurality of segmented electrodes and coupling a plurality of segmented electrodes to the insulative carrier. One of the plurality of segmented electrodes is disposed within each of the plurality of apertures and each of the plurality of segmented electrodes has at least one flange for securing the segmented electrode within the insulative carrier. The method also includes wrapping the insulative carrier around a mandrel to form a cylindrical lead body.
A further embodiment is a method of manufacturing a device for brain stimulation. The method includes forming an insulative tubing having a distal end section and forming at least one conductor lumen through the insulative tubing. The at least one conductor lumen extends longitudinally through the insulative tubing. The method further includes introducing a plurality of electrode tubes through the at least one conductor lumen of the insulative tubing, and removing a portion of the outer surface of the insulative tubing to expose a portion of a one of the at least one electrode tube
Non-limiting and non-exhaustive embodiments of the present invention are described with reference to the following drawings. In the drawings, like reference numerals refer to like parts throughout the various figures unless otherwise specified.
For a better understanding of the present invention, reference will be made to the following Detailed Description, which is to be read in association with the accompanying drawings, wherein:
The present invention is directed to the area of devices and methods for brain stimulation including deep brain stimulation. In addition, the invention is directed to devices and method for brain stimulation using a lead having a plurality of concentric windowed cylinders.
A lead for deep brain stimulation may include stimulation electrodes, recording electrodes, or a combination of both. A practitioner may determine the position of the target neurons using the recording electrode(s) and then position the stimulation electrode(s) accordingly without removal of a recording lead and insertion of a stimulation lead. In some embodiments, the same electrodes can be used for both recording and stimulation. In some embodiments, separate leads can be used; one with recording electrodes which identify target neurons, and a second lead with stimulation electrodes that replaces the first after target neuron identification. A lead may include recording electrodes spaced around the circumference of the lead to more precisely determine the position of the target neurons. In at least some embodiments, the lead is rotatable so that the stimulation electrodes can be aligned with the target neurons after the neurons have been located using the recording electrodes.
Deep brain stimulation devices and leads are described in the art. See, for instance, U.S. Patent Publication 2006/0149335 A1 (“Devices and Methods For Brain Stimulation”), and co-pending patent application U.S. Ser. No. 12/237,888 (“Leads With Non-Circular-Shaped Distal Ends For Brain Stimulation Systems and Methods of Making and Using”). Each of these references is incorporated herein by reference in its respective entirety.
In one example of operation, access to the desired position in the brain can be accomplished by drilling a hole in the patient's skull or cranium with a cranial drill (commonly referred to as a burr), and coagulating and incising the dura mater, or brain covering. The lead 1310 can be inserted into the cranium and brain tissue with the assistance of the stylet 1360. The lead can be guided to the target location within the brain using, for example, a stereotactic frame and a microdrive motor system. In some embodiments, the microdrive motor system can be fully or partially automatic. The microdrive motor system may be configured to perform one or more the following actions (alone or in combination): insert the lead, retract the lead, or rotate the lead. In some embodiments, measurement devices coupled to the muscles or other tissues stimulated by the target neurons or a unit responsive to the patient or clinician can be coupled to the control unit or microdrive motor system. The measurement device, user, or clinician can indicate a response by the target muscles or other tissues to the stimulation or recording electrode(s) to further identify the target neurons and facilitate positioning of the stimulation electrode(s). For example, if the target neurons are directed to a muscle experiencing tremors, a measurement device can be used to observe the muscle and indicate changes in tremor frequency or amplitude in response to stimulation of neurons. Alternatively, the patient or clinician may observe the muscle and provide feedback.
It will be understood that the lead 1310 for deep brain stimulation can include stimulation electrodes, recording electrodes, or both. In at least some embodiments, the lead is rotatable so that the stimulation electrodes can be aligned with the target neurons after the neurons have been located using the recording electrodes.
Stimulation electrodes may be disposed on the circumference of the lead to stimulate the target neurons. Stimulation electrodes may be ring-shaped so that current projects from each electrode equally in every direction at any given length along the axis of the lead. To achieve current steering, segmented electrodes can be utilized additionally or alternatively. Though the following description discusses stimulation electrodes, it will be understood that all configurations of the stimulation electrodes discussed may be utilized in arranging recording electrodes as well.
In the field of deep brain stimulation, radially segmented electrode arrays (RSEA) have been developed to provide superior radial selectivity of current. Radially segmented electrode arrays are useful for deep brain stimulation because the target structures in the deep brain are often not symmetric about the axis of the distal electrode array. In some cases, a target may be located on one side of a plane running through the axis of the lead. In other cases, a target may be located at a plane that is offset at some angle from the axis of the lead. Thus, radially segmented electrode arrays may be useful for selectively simulating tissue.
Stimulation electrodes may be disposed on the lead body 110. These stimulation electrodes may be made using a metal, alloy, conductive oxide, or any other suitable conductive material. Examples of suitable materials include, but are not limited to, platinum, iridium, platinum iridium alloy, stainless steel, titanium, or tungsten. Preferably, the stimulation electrodes are made of a material that is biocompatible and does not substantially corrode under expected operating conditions in the operating environment for the expected duration of use.
In at least some embodiments, any of the electrodes can be used as an anode or cathode and carry anodic or cathodic current. In some instances, an electrode might be an anode for a period of time and a cathode for a period of time. In other embodiments, the identity of a particular electrode or electrodes as an anode or cathode might be fixed.
The lead contains a plurality of segmented electrodes 130. Any number of segmented electrodes 130 may be disposed on the lead body 110. In some embodiments, the segmented electrodes 130 are grouped in sets of segmented electrodes, each set disposed around the circumference of the lead at or near a particular longitudinal position. The lead may have any number of sets of segmented electrodes. In at least some embodiments, the lead has one, two, three, four, five, six, seven, or eight sets of segmented electrodes. In at least some embodiments, each set of segmented electrodes contains the same number of segmented electrodes 130. In some embodiments, each set of segmented electrodes contains three segmented electrodes 130. In at least some other embodiments, each set of segmented electrodes contains two, four, five, six, seven or eight segmented electrodes. The segmented electrodes 130 may vary in size and shape. For example, in
In at least some embodiments, each set of segmented electrodes 130 may be disposed around the circumference of the lead body 110 to form a substantially or approximately cylindrical shape around the lead body 110. The spacing of the segmented electrodes 130 around the circumference of the lead body 110 may vary. In at least some embodiments, equal spaces, gaps or cutouts are disposed between each segmented electrodes 130 around the circumference of the lead body 110. In other embodiments, the spaces, gaps or cutouts between segmented electrodes may differ in size or shape. In other embodiments, the spaces, gaps, or cutouts between segmented electrodes may be uniform for a particular set of segmented electrodes or for all sets of segmented electrodes. The segmented electrodes 130 may be positioned in irregular or regular intervals around the lead body 110.
Stimulation electrodes in the form of ring electrodes 120 may be disposed on any part of the lead body 110, usually near a distal end of the lead.
In some embodiments, the ring electrodes 120 are substantially cylindrical and wrap around the entire circumference of the lead body 110. In some embodiments, the outer diameter of the ring electrodes 120 is substantially equal to the outer diameter of the lead body 110. Furthermore, the width of ring electrodes 120 may vary according to the desired treatment and the location of the target neurons. In some embodiments the width of the ring electrode 120 is less than or equal to the diameter of the ring electrode 120. In other embodiments, the width of the ring electrode 120 is greater than the diameter of the ring electrode 120.
Conductors (not shown) that attach to or from the ring electrodes 120 and segmented electrodes 130 also pass through the lead body 110. These conductors may pass through the material of the lead or through a lumen defined by the lead. The conductors are presented at a connector for coupling of the electrodes to a control unit (not shown). In one embodiment, the stimulation electrodes correspond to wire conductors that extend out of the lead body 110 and are then trimmed or ground down flush with the lead surface. The conductors may be coupled to a control unit to provide stimulation signals, often in the form of pulses, to the stimulation electrodes.
Any number of segmented electrodes 130 may be disposed on the lead body 110 in any number of sets.
Any combination of ring electrodes 120 and segmented electrodes 130 may be disposed on the lead. In some embodiments the segmented electrodes are arranged in sets. For example, a lead may include a first ring electrode 120, two sets of segmented electrodes, each set formed of three segmented electrodes 130, and a final ring electrode 120 at the end of the lead. This configuration may simply be referred to as a 1-3-3-1 configuration. It may be useful to refer to the electrodes with this shorthand notation. Other eight electrode configurations include, for example, a 2-2-2-2 configuration, where four sets of segmented electrodes are disposed on the lead, and a 4-4 configuration, where two sets of segmented electrodes, each having four segmented electrodes 130 are disposed on the lead. In some embodiments, the lead will have 16 electrodes. Possible configurations for a 16-electrode lead include, but are not limited to 4-4-4-4, 8-8, 3-3-3-3-3-1 (and all rearrangements of this configuration), and 2-2-2-2-2-2-2-2.
As can be appreciated from
In addition to 360° selectivity, a lead having segmented electrodes may provide several advantages. First, the lead may provide for more directed stimulation, as well as less “wasted” stimulation (i.e. stimulation of regions other than the target region). By directing stimulation toward the target tissue, side effects may be reduced. Furthermore, because stimulation is directed toward the target site, the battery in an implantable pulse generator may last for a longer period of time between recharging.
As previously indicated, the foregoing configurations may also be used while utilizing recording electrodes. In some embodiments, measurement devices coupled to the muscles or other tissues stimulated by the target neurons or a unit responsive to the patient or clinician can be coupled to the control unit or microdrive motor system. The measurement device, user, or clinician can indicate a response by the target muscles or other tissues to the stimulation or recording electrodes to further identify the target neurons and facilitate positioning of the stimulation electrodes. For example, if the target neurons are directed to a muscle experiencing tremors, a measurement device can be used to observe the muscle and indicate changes in tremor frequency or amplitude in response to stimulation of neurons. Alternatively, the patient or clinician may observe the muscle and provide feedback.
Radially segmented electrode arrays may be manufactured in a variety of ways, for example, by embedding or coupling conductive portions in a lead body. In at least some embodiments, a disk having an inner cavity may be used to form a radially segmented electrode array. The disk may define various lumens for housing conductors and for facilitating attachment to the lead body. Radially segmented electrode arrays may also be formed by disposing electrodes in an electrode frame or in a lumen defined by the lead body.
In some embodiments a pre-electrode is used to form a radially segmented electrode array.
The pre-electrode 300 defines a divider 310. The divider 310 may be formed of any shaped passage that extends through the longitudinal axis of the pre-electrode 300. As seen in
The pre-electrode 300 may include one or more conductor lumens 320. The conductor lumen 320 may be any lumen, hole, or passage that extends through the longitudinal axis of the pre-electrode 300. In some embodiments, the pre-electrode 300 includes one, two, three, four, five, six, eight, ten, or twelve conductor lumens 320. In some embodiments, the pre-electrode 300 includes one conductor lumen 320 for each segmented electrode that will be formed from the pre-electrode 300. For example, if a divider 310 is configured such that three segmented electrodes will be formed from the pre-electrode 300, then three conductor lumens 320 may be formed, one for each segmented electrode. The size of the conductor lumens 320 may be varied as needed. In some embodiments, the conductor lumens 320 are defined to have a circular cross-section corresponding to the cross-section of conductors that will be coupled to the electrodes. In some embodiments, the cross-section of the conductor lumens 320 are the same size and shape. Alternatively, the conductor lumens 320 may be formed in different shapes or sizes. For example, the conductor lumen 320 may have a cross-section that is in the shape of a square, a rectangle, an oval, or a triangle.
In some embodiments, the pre-electrode 300 includes one or more fixing lumens 330. The fixing lumen 330 may be any lumen, hole, or passage that extends through the longitudinal axis of the pre-electrode 300. In some embodiments, the fixing lumen 330 only partially extends through the longitudinal axis of the electrode 300. In at least some other embodiments, the fixing lumen 330 is defined as a through hole, a passage that extends through the full length of the pre-electrode 300. The fixing lumen 330 may be similar to the conductor lumen 320 in shape and size. The fixing lumen 330 may also be of different shape or size than the conductor lumen 320. In some embodiments, the fixing lumen 330 has a circular cross-section. As seen in
The pre-electrodes 300 may be formed larger in diameter than the lead body 110. Furthermore, the pre-electrodes 300 is yet undivided. In some embodiments, it may be useful or desirable to grind down the pre-electrode 300 to an appropriate diameter. After the pre-electrodes 300 have been ground down to the same level as the lead body 110, the lead 100 is isodiametric, having substantially the same diameter in all directions. The result is a substantially cylindrical lead 100 that is suitable for deep brain stimulation. Grinding down the pre-electrodes 300 is also capable of forming segmented electrodes 400 from the pre-electrodes 300. Preferably, the pre-electrodes are ground after the pre-electrodes are fixed within the lead and coupled to the conductors.
In some other embodiments a pre-formed electrode frame may be used to form a lead having a plurality of segmented electrodes.
The electrode frame 610 defines a plurality of electrode chambers 620 for accepting a plurality of segmented electrodes. The embodiment of
The segmented electrodes 710 may be formed of platinum, platinum-iridium, iridium, 316L stainless steel, tantalum, nitinol, a conductive polymer, or any other suitable conductive material.
Portions of the multi-lumen tubing 900 may be removed to allow the coupling of the electrode frame 610.
The electrode frames 610 may be coupled to the multi-lumen tubing 900.
As seen in
Liquid injected molding may also be used to create a lead array.
The carrier 1150 may also include side holes 1170 to allow for the passage of conductors (not shown) to the segmented electrodes 1110. In some embodiments, each aperture 1160 corresponds to one or more side holes 1170. The side holes 1170 may be formed in any edge or face of the carrier 1150. In some embodiments, as seen in
As seen in
In another embodiment, a tubing 1200 similar to that of the multi-lumen tubing 900 is provided. The tubing 1200 may be provided with a plurality of conductor lumens 1220. The tubing 1200 may also include a central passage 1210 configured for receiving an insertion instrument such as a stylet. Pre-welded electrode tubes 1250 may be disposed within the conductor lumens 1220.
In some embodiment, the electrode tubes 1250 have a groove 1270 that may be useful in coupling the electrode tube 1250 to the tubing 1200. As seen in
With the electrode tubes 1250 disposed within the multi-lumen tubing 1200, techniques such as grinding or ablation may be used to expose portions of the electrode tubes 1250 by removing portions of the outer surface of the tubing 1200. As seen in
Modifications of these methods are possible. For example, one or more combinations of the above methods may be used to form a lead as desired. In some embodiments, these methods are used with lead constructions other than deep brain stimulation leads.
The above specification, examples and data provide a description of the manufacture and use of the composition of the invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention also resides in the claims hereinafter appended.
This application is a divisional of U.S. patent application Ser. No. 13/159,040 filed Jun. 13, 2011 which claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Patent Application Ser. No. 61/356,529 filed on Jun. 18, 2010, both of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4602624 | Naples et al. | Jul 1986 | A |
4630611 | King | Dec 1986 | A |
4744370 | Harris | May 1988 | A |
5000194 | van den Honert et al. | Mar 1991 | A |
5135001 | Sinofsky et al. | Aug 1992 | A |
5374285 | Vaiani et al. | Dec 1994 | A |
5458629 | Baudino et al. | Oct 1995 | A |
5522874 | Gates | Jun 1996 | A |
5711316 | Elsberry et al. | Jan 1998 | A |
5713922 | King | Feb 1998 | A |
5800350 | Coppleson et al. | Sep 1998 | A |
5843148 | Gijsbers et al. | Dec 1998 | A |
5938688 | Schiff | Aug 1999 | A |
5987361 | Mortimer | Nov 1999 | A |
6018684 | Bartig et al. | Jan 2000 | A |
6134478 | Spehr | Oct 2000 | A |
6161047 | King et al. | Dec 2000 | A |
6167311 | Rezai | Dec 2000 | A |
6322559 | Daulton et al. | Nov 2001 | B1 |
6343226 | Sunde et al. | Jan 2002 | B1 |
6510347 | Borkan | Jan 2003 | B2 |
6556873 | Smits | Apr 2003 | B1 |
6560472 | Hill et al. | May 2003 | B2 |
6564078 | Marino et al. | May 2003 | B1 |
6678564 | Ketterl et al. | Jan 2004 | B2 |
6757970 | Kuzma et al. | Jul 2004 | B1 |
7006859 | Osorio et al. | Feb 2006 | B1 |
7027852 | Helland | Apr 2006 | B2 |
7047084 | Erickson et al. | May 2006 | B2 |
7190989 | Swanson et al. | Mar 2007 | B1 |
7203548 | Whitehurst et al. | Apr 2007 | B2 |
7285118 | Lozano | Oct 2007 | B1 |
7292890 | Whitehurst et al. | Nov 2007 | B2 |
7489971 | Franz | Feb 2009 | B1 |
7668601 | Hegland et al. | Feb 2010 | B2 |
7761985 | Hegland et al. | Jul 2010 | B2 |
7809446 | Meadows | Oct 2010 | B2 |
7822482 | Gerber | Oct 2010 | B2 |
7840188 | Kurokawa | Nov 2010 | B2 |
7848802 | Goetz | Dec 2010 | B2 |
7856707 | Cole | Dec 2010 | B2 |
7860570 | Whitehurst et al. | Dec 2010 | B2 |
7974705 | Zdeblick et al. | Jul 2011 | B2 |
7979140 | Schulman | Jul 2011 | B2 |
8000808 | Hegland et al. | Aug 2011 | B2 |
8019440 | Kokones et al. | Sep 2011 | B2 |
8036755 | Franz | Oct 2011 | B2 |
8041309 | Kurokawa | Oct 2011 | B2 |
8099177 | Dahlberg | Jan 2012 | B2 |
8225504 | Dye et al. | Jul 2012 | B2 |
8295944 | Howard et al. | Oct 2012 | B2 |
8321025 | Bedenbaugh | Nov 2012 | B2 |
8359107 | Pianca et al. | Jan 2013 | B2 |
8391985 | McDonald | Mar 2013 | B2 |
8583237 | Bedenbaugh | Nov 2013 | B2 |
8649873 | Moffitt et al. | Feb 2014 | B2 |
9381348 | Romero | Jul 2016 | B2 |
20010023368 | Black et al. | Sep 2001 | A1 |
20020156513 | Borkan | Oct 2002 | A1 |
20020183817 | Van Venrooij et al. | Dec 2002 | A1 |
20050015130 | Gill | Jan 2005 | A1 |
20050038489 | Grill | Feb 2005 | A1 |
20050171587 | Daglow et al. | Aug 2005 | A1 |
20060025841 | McIntyre | Feb 2006 | A1 |
20060168805 | Hegland et al. | Aug 2006 | A1 |
20060247697 | Sharma et al. | Nov 2006 | A1 |
20070038279 | Fifer et al. | Feb 2007 | A1 |
20070168007 | Kuzma et al. | Jul 2007 | A1 |
20070203546 | Stone et al. | Aug 2007 | A1 |
20070219551 | Honour et al. | Sep 2007 | A1 |
20080077186 | Thompson et al. | Mar 2008 | A1 |
20080103580 | Gerber | May 2008 | A1 |
20080114230 | Addis | May 2008 | A1 |
20080139913 | Schulman | Jun 2008 | A1 |
20080215125 | Farah et al. | Sep 2008 | A1 |
20080255647 | Jensen et al. | Oct 2008 | A1 |
20090054941 | Eggen et al. | Feb 2009 | A1 |
20090204192 | Carlton et al. | Aug 2009 | A1 |
20100030298 | Martens et al. | Feb 2010 | A1 |
20100036468 | Decre et al. | Feb 2010 | A1 |
20100076535 | Pianca et al. | Mar 2010 | A1 |
20100077606 | Black et al. | Apr 2010 | A1 |
20100082076 | Lee et al. | Apr 2010 | A1 |
20100094387 | Pianca et al. | Apr 2010 | A1 |
20100100152 | Martens et al. | Apr 2010 | A1 |
20100268298 | Moffitt et al. | Oct 2010 | A1 |
20100269338 | Dye | Oct 2010 | A1 |
20100269339 | Dye et al. | Oct 2010 | A1 |
20100287770 | Dadd et al. | Nov 2010 | A1 |
20110005069 | Pianca | Jan 2011 | A1 |
20110047795 | Turner et al. | Mar 2011 | A1 |
20110056076 | Hegland et al. | Mar 2011 | A1 |
20110077699 | Swanson et al. | Mar 2011 | A1 |
20110078900 | Pianca et al. | Apr 2011 | A1 |
20110130803 | McDonald | Jun 2011 | A1 |
20110130816 | Howard et al. | Jun 2011 | A1 |
20110130817 | Chen | Jun 2011 | A1 |
20110130818 | Chen | Jun 2011 | A1 |
20110131808 | Gill | Jun 2011 | A1 |
20110238129 | Moffitt et al. | Sep 2011 | A1 |
20110245903 | Schulte et al. | Oct 2011 | A1 |
20110301665 | Mercanzini et al. | Dec 2011 | A1 |
20110313500 | Barker et al. | Dec 2011 | A1 |
20120016378 | Pianca et al. | Jan 2012 | A1 |
20120046710 | DiGiore et al. | Feb 2012 | A1 |
20120071949 | Pianca et al. | Mar 2012 | A1 |
20120165911 | Pianca | Jun 2012 | A1 |
20120197375 | Pianca et al. | Aug 2012 | A1 |
20120203316 | Moffitt et al. | Aug 2012 | A1 |
20120203320 | DiGiore et al. | Aug 2012 | A1 |
20120203321 | Moffitt et al. | Aug 2012 | A1 |
20130109254 | Klardie et al. | May 2013 | A1 |
20130197424 | Bedenbaugh | Aug 2013 | A1 |
20130197602 | Pianca et al. | Aug 2013 | A1 |
20130261684 | Howard | Oct 2013 | A1 |
20130317587 | Barker | Nov 2013 | A1 |
20130325091 | Pianca et al. | Dec 2013 | A1 |
20140039587 | Romero | Feb 2014 | A1 |
20140039590 | Moffitt et al. | Feb 2014 | A1 |
20140088666 | Goetz et al. | Mar 2014 | A1 |
20140123484 | DiGiore et al. | May 2014 | A1 |
20140142671 | Moffitt et al. | May 2014 | A1 |
20140155971 | Pianca et al. | Jun 2014 | A1 |
20140180375 | Pianca et al. | Jun 2014 | A1 |
Number | Date | Country |
---|---|---|
0580928 | Feb 1994 | EP |
0650694 | Jul 1998 | EP |
0832667 | Feb 2004 | EP |
1181947 | Jan 2006 | EP |
2092952 | Aug 2009 | EP |
1997032628 | Sep 1997 | WO |
1999055411 | Feb 2000 | WO |
2000038574 | Jul 2000 | WO |
2001058520 | Aug 2001 | WO |
2002068042 | Sep 2002 | WO |
2004045707 | Jun 2004 | WO |
2008018067 | Feb 2008 | WO |
2008053789 | May 2008 | WO |
2008100841 | Aug 2008 | WO |
2009001327 | Dec 2008 | WO |
2009025816 | Feb 2009 | WO |
2009102536 | Aug 2009 | WO |
2010055421 | May 2010 | WO |
2010060011 | May 2010 | WO |
2013162775 | Oct 2013 | WO |
2014018092 | Jan 2014 | WO |
Entry |
---|
U.S. Appl. No. 14/286,940, filed May 23, 2014. |
U.S. Appl. No. 14/286,889, filed May 23, 2014. |
U.S. Appl. No. 14/286,829, filed May 23, 2014. |
U.S. Appl. No. 14/325,249, filed Jul. 7, 2014. |
U.S. Appl. No. 14/332,212, filed Jul. 15, 2014. |
U.S. Appl. No. 14/452,461, filed Aug. 5, 2014. |
U.S. Appl. No. 14/286,797, filed May 23, 2014. |
U.S. Appl. No. 14/286,934, filed May 23, 2014. |
International Search Report and Written Opinion for International Patent Application No. PCT/US2011/040229, dated Dec. 19, 2011. |
Official Communication for U.S. Appl. No. 13/159,040, dated May 14, 2014. |
Official Communication for U.S. Appl. No. 13/159,040, dated Jun. 4, 2013. |
Official Communication for U.S. Appl. No. 13/159,040, dated Feb. 8, 2013. |
U.S. Appl. No. 14/469,214, filed Aug. 26, 2014. |
U.S. Appl. No. 14/557,211, filed Dec. 1, 2014. |
International Search Report and Written Opinion for International Patent Application No. PCT/US2011/040229 dated Dec. 19, 2011. |
Number | Date | Country | |
---|---|---|---|
20150000124 A1 | Jan 2015 | US |
Number | Date | Country | |
---|---|---|---|
61356529 | Jun 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13159040 | Jun 2011 | US |
Child | 14486842 | US |